Burcu Isler

8PUBLICATIONS
16CO-AUTHORS
Innate immunityMedical infection agents (incl. prions)OrthopaedicsCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
Immunoglobulin A vasculitis in association with invasive meningococcal disease.

|Oct 09, 2025
Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa.

Juan P Horcajada, Ana C Gales, Burcu Isler

|Aug 14, 2025
Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidence.

Burcu Isler, Zhenya Welyczko, Nicholas Jorgensen

|Jul 05, 2021
PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales.

David L Paterson, Burcu Isler, Patrick N A Harris

|Oct 13, 2020
Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing Enterobacterales?: a Systematic Review and Meta-analysis.

Burcu Isler, Yukiko Ezure, Jose Luis García-Fogeda Romero

|Aug 21, 2020
Achromobacter Infections and Treatment Options.

Burcu Isler, Timothy J Kidd, Adam G Stewart

Pageof 2

Frequent Collaborators

3 joint publications

David L Paterson

2 joint publications

Patrick N A Harris

2 joint publications

Joshua S Davis

1 joint publications

Adam G Stewart